Kathryn A. Torres Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Kathryn A. Torres has an estimated net worth of at least $11.9 million*, as of Dec. 18, 2024. They own 17,755 shares of HCA stock. They have sold 22,121 shares of HCA stock since 2021, for an estimated $6.4 million.
Kathryn A. Torres $HCA SEC Form 4 Insider Trading
Kathryn A. Torres has filed a total of 10 insider trades in $HCA since 2021. Their most recent trade was a sale of 1,857 shares, made on Jul 25, 2024. Their largest trade was a sale of 5,204 shares, made on Aug 14, 2023. We estimate that they now own 17,755 shares of $HCA, worth an estimated $5.5 million.
Insider Trading at $HCA
There have been a total of 96 insider trades reported at $HCA since 2021, with 91,695 shares purchased and 488,240 shares sold. The most active insider traders in $HCA stock have been Kathryn A. Torres, Kathleen M Whalen, and Michael S. Cuffe. The most recent trade was a sale of 1,474 shares reported by Kathleen M Whalen (SVP & Chief Ethics Officer), made on Nov 14, 2024.
History of Insider Stock Trades by Kathryn A. Torres
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
HCA
|
Sale | 1,857 | Jul 25, 2024 | July 29, 2024, 5:18 p.m. |
|
HCA
|
Sale | 1,863 | May 15, 2024 | May 17, 2024, 5:14 p.m. |
|
HCA
|
Sale | 973 | May 02, 2024 | May 6, 2024, 6:39 p.m. |
|
HCA
|
Sale | 890 | May 03, 2024 | May 6, 2024, 6:39 p.m. |
|
HCA
|
Sale | 3,861 | Jan 31, 2024 | Feb. 2, 2024, 7:51 p.m. |
|
HCA
|
Sale | 5,204 | Aug 14, 2023 | Aug. 16, 2023, 5:12 p.m. |
|
HCA
|
Sale | 4,473 | Apr 24, 2023 | April 26, 2023, 4:55 p.m. |
|
HCA
|
Sale | 300 | Oct 24, 2022 | Oct. 26, 2022, 6:22 p.m. |
|
HCA
|
Sale | 1,700 | Oct 24, 2022 | Oct. 26, 2022, 6:22 p.m. |
|
HCA
|
Sale | 1,000 | Jul 21, 2021 | July 22, 2021, 8 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Charles J Hall, Group President
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Bill B Rutherford, CFO and EVP
-
Christopher F. Wyatt, SVP & Controller
-
Samuel N Hazen, CEO
-
Phillip G Billington, SVP-Internal Audit Services
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Jeffrey E. Cohen, SVP-Government Relations
-
Timothy M Mcmanus, Group President
-
Jon M Foster, EVP and COO
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.